National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 422374

Case Details

VAERS ID: 422374 (history)  
Age: 14.0  
Gender: Female  
Location: New York  
Vaccinated:2008-04-29
Onset:2011-02-01
   Days after vaccination:1008
Submitted: 2011-05-05
   Days after onset:92
Entered: 2011-05-06
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1978U / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Blood test, Electromyogram normal, Guillain-Barre syndrome, Laboratory test normal, Muscular weakness, Nerve conduction studies normal, Neurological examination abnormal, Neuromyopathy, Pain in extremity, Tremor, Walking aid user
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Gilbert''s syndrome
Preexisting Conditions:
Diagnostic Lab Data: Electromyography, ?/?/11, normal; Nerve conduction study, ?/?/11, nerve conduction velocity (NCV) was normal; Laboratory test, ?/?/11, normal, unknown which tests were done
CDC Split Type: WAES1104USA00008

Write-up: Information has been received from a physician concerning a 17 year old female patient with Gilbert''s syndrome (benign syndrome with normal variance) and no known drug allergies who received GARDASIL series (first dose on 10-Sep-2007, lot # 658554/0928U; second dose on 26-Nov-2007, lot # 659439/1267U; third dose on 29-Apr-2008, lot # 659964/1978U). There was no concomitant medication. In approximately February 2011 ("about 1 1/2 months before diagnosis date of 31-MAR-2011"), the patient experienced weakness, trembling and pain in her legs. So she went to the emergency department at a hospital. The symptoms had been processing to her arms. Blood tests were ordered at the emergency department but the results were not available for him to review. Lab work performed (unknown which tests were done) was normal according to the patient''s mother. It was believed that no cerebrospinal fluid (CSF) analysis was performed. ON 31-MAR-2011 the patient was diagnosed with Guillain-Barre syndrome by the reporting physician. The physician referred the patient to a neurologist on 31-MAR-2011 who confirmed his diagnosis of Guillain-Barre syndrome. At the time of reporting, the patient had not recovered from Guillain-Barre syndrome. Follow up information has been received from the neurologist who reported that no vaccine was given to the student patient at his office. The patient was seen in office for neurological evaluation secondary to lower extremity weakness and was diagnosed with idiopathic cryptogenic neuromuscular disorder. There was no history of vaccine exposure given at that time related/unrelated. No evidence vaccine. Electromyography (EMG) and nerve conduction velocity (NCV) were performed and both were normal. On 13-APR-2011, the patient recovered from the adverse event. Guillain-Barre syndrome was not life threatening, but was disabling in the fact that the patient needed assistance with walking. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=422374


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166